Document Detail


Imiquimod use in the treatment of lentigo maligna.
MedLine Citation:
PMID:  19836644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Jacqueline M. Junkins-Hopkins, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology.
Authors:
Jacqueline M Junkins-Hopkins
Related Documents :
18280344 - Psoriasis: the heart of the matter.
17707154 - Peutz-jeghers syndrome.
20432184 - American academy of allergy, asthma and immunology (aaaai)-2010 annual meeting. 26 febr...
11645704 - Unesco conference on human rights and bioethics.
17911714 - Using fieldwork in analyzing ethical issues related to it in health care.
22132274 - Incoming interns' perspectives on the institute of medicine recommendations for residen...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  61     ISSN:  1097-6787     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-19     Completed Date:  2009-11-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  865-7     Citation Subset:  IM    
Affiliation:
Division of Dermatopathology and Oral Pathology, Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA. jjunkin1@jhmi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Immunologic / administration & dosage*
Administration, Topical
Aged
Aminoquinolines / administration & dosage*
Humans
Hutchinson's Melanotic Freckle / drug therapy*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Aminoquinolines; 99011-02-6/imiquimod

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Calcineurin inhibitors in oral medicine.
Next Document:  Nephrogenic systemic fibrosis-a rapidly progressive disabling disease with limited therapeutic optio...